Ilika publishes 2025 Annual Report, advancing Goliath and Stereax

IKA

Ilika Plc (LON:IKA), a pioneer in solid-state battery technology, has given formal notice that the Company’s Annual General Meeting will be held on Tuesday, 23 September 2025 at 2.00 pm (BST) at the offices of Eversheds Sutherland LLP, One Wood Street, London EC2V 7WS.

If you wish to attend the AGM in your capacity as a shareholder, please bring proof of shareholding or, if shares are held through a nominee account, a letter of representation, to facilitate your entry to the Meeting. If you are not planning to attend the meeting and would like someone else to vote for you at the meeting (or any adjournment of the meeting), please complete the form of proxy, which can be accessed using the following link www.investorcentre.co.uk/eproxy

Shareholders are encouraged to appoint the Chairman of the Meeting as their proxy with their voting instructions. Please vote online at www.investorcentre.co.uk/eproxy and enter the Control Number, your Shareholder Reference Number (SRN), and PIN as shown on the Proxy Form.

To be valid, proxy appointments for the Annual General Meeting must be received by the Company’s Registrar, Computershare Investor Services PLC, no later than 2.00 pm (BST) on 19 September 2025.

Posting of Annual Report and AGM Notice

The Company confirms that the Annual Report and Accounts for the year ended 30 April 2025 and the Notice of the 2025 Annual General Meeting (‘AGM’) will be made available shortly to view or download by clicking the links below:

–  Ilika plc Notice of Annual General Meeting: https://www.ilika.com/investors/aim-rule-26

–  Ilika plc Annual Report and Accounts: 

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika’s Stereax batteries set for Medical Technology Ireland showcase

Ilika’s Stereax batteries will be showcased by Cirtec Medical at Medical Technology Ireland, giving the company targeted exposure in the medical device market.

Ilika CEO Graeme Purdy discusses Stereax revenues and Goliath opportunities

Ilika CEO Graeme Purdy discusses first Stereax revenues, grant support for Goliath, EV market trends, and opportunities in defence and e-bikes.

Ilika positions solid state batteries for the future of implantable neurostimulation

Ilika’s Stereax solid state battery technology supports the development of smaller, safer and more practical implantable neurostimulation devices for emerging medical applications.

Ilika advances manufacturing readiness for solid-state batteries

Ilika’s collaboration with UKBIC shows how manufacturing validation is helping move its Goliath pouch cell technology closer to commercial readiness.

Ilika reports first Stereax revenues and Goliath progress

Ilika expects FY26 revenue of approximately ÂŁ1.1m, including first commercial Stereax electrode sales, with Goliath evaluation activity expanding across automotive, defence and e-bike applications.

Search